Literature DB >> 11007353

Mechanisms of chronic rejection.

A M Waaga1, M Gasser, I Laskowski, N L Tilney.   

Abstract

Chronic rejection remains the major obstacle to long-term allograft survival. Detailed understanding of putative etiologic risk factors, both antigen-dependent and -independent, is important for designing effective therapeutic strategies to ameliorate this process. Cell senescence may be an important factor in chronic rejection.

Mesh：

Substances：

Year:  2000        PMID： 11007353     DOI： 10.1016/s0952-7915(00)00132-1

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  9 in total

1.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

Review 2.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

Review 3.  TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.

Authors:  Adam J Booth; D Keith Bishop
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

4.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

5.  Kimura disease in a patient with renal allograft failure secondary to chronic rejection.

Authors:  Hsiang-Ju Lu; Jeng-Daw Tsai; Jin-Cherng Sheu; Chin-Yuan Tzen; Tsuen-Chiuan Tsai; Chun-Chen Lin; Fu-Yuan Huang
Journal:  Pediatr Nephrol       Date:  2003-07-12       Impact factor: 3.714

6.  Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Bernard L Marini; Weiping Zou; David Gordon; Yoichiro Iwakura; Yasmina Laouar; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

Review 7.  Chemokines and transplant vasculopathy.

Authors:  John A Belperio; Abbas Ardehali
Journal:  Circ Res       Date:  2008-08-29       Impact factor: 17.367

8.  Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts.

Authors:  Huijun Ying; Hongmei Fu; Marlene L Rose; Ann M McCormack; Padmini Sarathchandra; Klaus Okkenhaug; Federica M Marelli-Berg
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.

Authors:  Benjamin D Medoff; Edward Seung; John C Wain; Terry K Means; Gabriele S V Campanella; Sabina A Islam; Seddon Y Thomas; Leo C Ginns; Nir Grabie; Andrew H Lichtman; Andrew M Tager; Andrew D Luster
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.